avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Stat5a
|
ENSMUSG00000004043.8 | signal transducer and activator of transcription 5A |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Stat5a | mm10_v2_chr11_+_100860447_100860537 | -0.45 | 5.7e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_61303998 | 8.36 |
ENSMUST00000071005.8
ENSMUST00000075206.5 |
Mup14
|
major urinary protein 14 |
chr9_-_48605147 | 8.34 |
ENSMUST00000034808.5
ENSMUST00000119426.1 |
Nnmt
|
nicotinamide N-methyltransferase |
chr4_-_60582152 | 7.85 |
ENSMUST00000098047.2
|
Mup10
|
major urinary protein 10 |
chr6_-_41377604 | 7.81 |
ENSMUST00000096003.5
|
Prss3
|
protease, serine, 3 |
chr6_+_41354105 | 7.45 |
ENSMUST00000072103.5
|
Try10
|
trypsin 10 |
chr6_+_41521782 | 7.39 |
ENSMUST00000070380.4
|
Prss2
|
protease, serine, 2 |
chr4_-_60421933 | 6.93 |
ENSMUST00000107506.2
ENSMUST00000122381.1 ENSMUST00000118759.1 ENSMUST00000122177.1 |
Mup9
|
major urinary protein 9 |
chr4_+_115299046 | 6.86 |
ENSMUST00000084343.3
|
Cyp4a12a
|
cytochrome P450, family 4, subfamily a, polypeptide 12a |
chr4_-_60501903 | 6.71 |
ENSMUST00000084548.4
ENSMUST00000103012.3 ENSMUST00000107499.3 |
Mup1
|
major urinary protein 1 |
chr4_-_60741275 | 6.26 |
ENSMUST00000117932.1
|
Mup12
|
major urinary protein 12 |
chr4_-_61303802 | 6.12 |
ENSMUST00000125461.1
|
Mup14
|
major urinary protein 14 |
chr4_+_115411624 | 5.95 |
ENSMUST00000094887.3
|
Cyp4a12b
|
cytochrome P450, family 4, subfamily a, polypeptide 12B |
chr6_-_41035501 | 5.62 |
ENSMUST00000031931.5
|
2210010C04Rik
|
RIKEN cDNA 2210010C04 gene |
chr6_+_78425973 | 5.26 |
ENSMUST00000079926.5
|
Reg1
|
regenerating islet-derived 1 |
chr7_+_43995833 | 4.78 |
ENSMUST00000007156.4
|
Klk1b11
|
kallikrein 1-related peptidase b11 |
chr6_+_40964760 | 4.40 |
ENSMUST00000076638.5
|
1810009J06Rik
|
RIKEN cDNA 1810009J06 gene |
chr4_-_62087261 | 4.10 |
ENSMUST00000107488.3
ENSMUST00000107472.1 ENSMUST00000084531.4 |
Mup3
|
major urinary protein 3 |
chr6_-_41446062 | 3.83 |
ENSMUST00000095999.5
|
Gm10334
|
predicted gene 10334 |
chr4_-_60139857 | 3.73 |
ENSMUST00000107490.4
ENSMUST00000074700.2 |
Mup2
|
major urinary protein 2 |
chr6_-_78378851 | 3.62 |
ENSMUST00000089667.1
ENSMUST00000167492.1 |
Reg3d
|
regenerating islet-derived 3 delta |
chr7_-_30944017 | 3.62 |
ENSMUST00000062620.7
|
Hamp
|
hepcidin antimicrobial peptide |
chr3_-_20275659 | 3.55 |
ENSMUST00000011607.5
|
Cpb1
|
carboxypeptidase B1 (tissue) |
chr4_-_60499332 | 3.41 |
ENSMUST00000135953.1
|
Mup1
|
major urinary protein 1 |
chr7_+_44198191 | 3.40 |
ENSMUST00000085450.2
|
Klk1b3
|
kallikrein 1-related peptidase b3 |
chr7_+_44216456 | 3.40 |
ENSMUST00000074359.2
|
Klk1b5
|
kallikrein 1-related peptidase b5 |
chr6_+_78370877 | 3.25 |
ENSMUST00000096904.3
|
Reg3b
|
regenerating islet-derived 3 beta |
chr10_+_84838143 | 3.23 |
ENSMUST00000095388.4
|
Rfx4
|
regulatory factor X, 4 (influences HLA class II expression) |
chr1_+_88087802 | 3.20 |
ENSMUST00000113139.1
|
Ugt1a8
|
UDP glucuronosyltransferase 1 family, polypeptide A8 |
chr3_+_63295815 | 3.09 |
ENSMUST00000029400.1
|
Mme
|
membrane metallo endopeptidase |
chr6_+_142298419 | 3.07 |
ENSMUST00000041993.2
|
Iapp
|
islet amyloid polypeptide |
chr9_-_57683644 | 2.98 |
ENSMUST00000034860.3
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr6_+_41458923 | 2.94 |
ENSMUST00000031910.7
|
Prss1
|
protease, serine, 1 (trypsin 1) |
chr7_-_131322292 | 2.87 |
ENSMUST00000046611.7
|
Cuzd1
|
CUB and zona pellucida-like domains 1 |
chr6_-_85820965 | 2.86 |
ENSMUST00000032074.3
|
Cml5
|
camello-like 5 |
chr5_-_108795352 | 2.80 |
ENSMUST00000004943.1
|
Tmed11
|
transmembrane emp24 protein transport domain containing |
chr7_-_30924169 | 2.76 |
ENSMUST00000074671.6
|
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr6_-_78468863 | 2.72 |
ENSMUST00000032089.2
|
Reg3g
|
regenerating islet-derived 3 gamma |
chr8_+_105269837 | 2.61 |
ENSMUST00000172525.1
ENSMUST00000174837.1 ENSMUST00000173859.1 |
Hsf4
|
heat shock transcription factor 4 |
chr6_+_41392356 | 2.60 |
ENSMUST00000049079.7
|
Gm5771
|
predicted gene 5771 |
chr7_+_87246649 | 2.52 |
ENSMUST00000068829.5
ENSMUST00000032781.7 |
Nox4
|
NADPH oxidase 4 |
chr6_+_138141569 | 2.50 |
ENSMUST00000118091.1
|
Mgst1
|
microsomal glutathione S-transferase 1 |
chr12_-_104044431 | 2.48 |
ENSMUST00000043915.3
|
Serpina12
|
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
chr3_-_75270073 | 2.46 |
ENSMUST00000039047.4
|
Serpini2
|
serine (or cysteine) peptidase inhibitor, clade I, member 2 |
chr19_-_8131982 | 2.44 |
ENSMUST00000065651.4
|
Slc22a28
|
solute carrier family 22, member 28 |
chr7_+_44225430 | 2.44 |
ENSMUST00000075162.3
|
Klk1
|
kallikrein 1 |
chr8_+_45069137 | 2.37 |
ENSMUST00000067984.7
|
Mtnr1a
|
melatonin receptor 1A |
chr7_-_99695628 | 2.34 |
ENSMUST00000145381.1
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr8_+_104926237 | 2.32 |
ENSMUST00000034355.4
ENSMUST00000109410.2 |
Ces2e
|
carboxylesterase 2E |
chr6_+_78380700 | 2.29 |
ENSMUST00000101272.1
|
Reg3a
|
regenerating islet-derived 3 alpha |
chr7_+_119526269 | 2.19 |
ENSMUST00000066465.1
|
Acsm5
|
acyl-CoA synthetase medium-chain family member 5 |
chr15_-_5063741 | 2.19 |
ENSMUST00000110689.3
|
C7
|
complement component 7 |
chr7_-_99695809 | 2.14 |
ENSMUST00000107086.2
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr7_+_107567445 | 2.14 |
ENSMUST00000120990.1
|
Olfml1
|
olfactomedin-like 1 |
chr1_+_88095054 | 2.08 |
ENSMUST00000150634.1
ENSMUST00000058237.7 |
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C |
chr4_+_60003438 | 2.06 |
ENSMUST00000107517.1
ENSMUST00000107520.1 |
Mup6
|
major urinary protein 6 |
chr19_+_4711153 | 2.04 |
ENSMUST00000008991.6
|
Sptbn2
|
spectrin beta, non-erythrocytic 2 |
chr15_+_9335550 | 1.93 |
ENSMUST00000072403.6
|
Ugt3a2
|
UDP glycosyltransferases 3 family, polypeptide A2 |
chr15_+_10223974 | 1.91 |
ENSMUST00000128450.1
ENSMUST00000148257.1 ENSMUST00000128921.1 |
Prlr
|
prolactin receptor |
chr16_-_18089022 | 1.91 |
ENSMUST00000132241.1
ENSMUST00000139861.1 ENSMUST00000003620.5 |
Prodh
|
proline dehydrogenase |
chr17_-_12675833 | 1.89 |
ENSMUST00000024596.8
|
Slc22a1
|
solute carrier family 22 (organic cation transporter), member 1 |
chr11_-_11890368 | 1.88 |
ENSMUST00000155690.1
|
Ddc
|
dopa decarboxylase |
chr19_+_12633303 | 1.88 |
ENSMUST00000044976.5
|
Glyat
|
glycine-N-acyltransferase |
chr14_+_30886521 | 1.83 |
ENSMUST00000168782.1
|
Itih4
|
inter alpha-trypsin inhibitor, heavy chain 4 |
chr18_-_74961252 | 1.83 |
ENSMUST00000066532.4
|
Lipg
|
lipase, endothelial |
chr3_-_81975742 | 1.80 |
ENSMUST00000029645.8
|
Tdo2
|
tryptophan 2,3-dioxygenase |
chr14_+_30886476 | 1.80 |
ENSMUST00000006703.6
ENSMUST00000078490.5 ENSMUST00000120269.2 |
Itih4
|
inter alpha-trypsin inhibitor, heavy chain 4 |
chr6_-_85832082 | 1.79 |
ENSMUST00000032073.6
|
Nat8
|
N-acetyltransferase 8 (GCN5-related, putative) |
chr4_-_141846359 | 1.79 |
ENSMUST00000037059.10
|
Ctrc
|
chymotrypsin C (caldecrin) |
chr15_-_76307231 | 1.79 |
ENSMUST00000023222.6
ENSMUST00000164189.1 |
Oplah
|
5-oxoprolinase (ATP-hydrolysing) |
chr5_-_87254804 | 1.76 |
ENSMUST00000075858.3
|
Ugt2b37
|
UDP glucuronosyltransferase 2 family, polypeptide B37 |
chr7_+_63916857 | 1.75 |
ENSMUST00000177638.1
|
E030018B13Rik
|
RIKEN cDNA E030018B13 gene |
chr11_-_4160286 | 1.74 |
ENSMUST00000093381.4
ENSMUST00000101626.2 |
Ccdc157
|
coiled-coil domain containing 157 |
chr3_-_122924103 | 1.74 |
ENSMUST00000180557.1
|
4933405D12Rik
|
RIKEN cDNA 4933405D12 gene |
chrX_-_61185558 | 1.72 |
ENSMUST00000166381.1
|
Cdr1
|
cerebellar degeneration related antigen 1 |
chr10_+_87521920 | 1.65 |
ENSMUST00000142088.1
|
Pah
|
phenylalanine hydroxylase |
chr12_-_30373358 | 1.64 |
ENSMUST00000021004.7
|
Sntg2
|
syntrophin, gamma 2 |
chr1_-_139781236 | 1.60 |
ENSMUST00000027612.8
ENSMUST00000111989.2 ENSMUST00000111986.2 |
Gm4788
|
predicted gene 4788 |
chr1_+_96872221 | 1.55 |
ENSMUST00000181489.1
|
Gm5101
|
predicted gene 5101 |
chr16_-_23890805 | 1.53 |
ENSMUST00000004480.3
|
Sst
|
somatostatin |
chr2_+_164403194 | 1.53 |
ENSMUST00000017151.1
|
Rbpjl
|
recombination signal binding protein for immunoglobulin kappa J region-like |
chr5_-_87337165 | 1.52 |
ENSMUST00000031195.2
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr13_-_41847482 | 1.52 |
ENSMUST00000072012.3
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr18_-_38866702 | 1.50 |
ENSMUST00000115582.1
|
Fgf1
|
fibroblast growth factor 1 |
chr5_-_87424201 | 1.49 |
ENSMUST00000072818.5
|
Ugt2b38
|
UDP glucuronosyltransferase 2 family, polypeptide B38 |
chr7_+_140763739 | 1.47 |
ENSMUST00000026552.7
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr4_-_49473905 | 1.47 |
ENSMUST00000135976.1
|
Acnat1
|
acyl-coenzyme A amino acid N-acyltransferase 1 |
chr10_+_87521795 | 1.46 |
ENSMUST00000020241.8
|
Pah
|
phenylalanine hydroxylase |
chr10_+_62071014 | 1.45 |
ENSMUST00000053865.5
|
Gm5424
|
predicted gene 5424 |
chr1_-_51915968 | 1.44 |
ENSMUST00000046390.7
|
Myo1b
|
myosin IB |
chr3_+_19957037 | 1.44 |
ENSMUST00000091309.5
ENSMUST00000108329.1 ENSMUST00000003714.6 |
Cp
|
ceruloplasmin |
chr10_+_87521954 | 1.43 |
ENSMUST00000143624.1
|
Pah
|
phenylalanine hydroxylase |
chr1_-_75278345 | 1.42 |
ENSMUST00000039534.4
|
Resp18
|
regulated endocrine-specific protein 18 |
chr11_-_11890394 | 1.42 |
ENSMUST00000109659.2
|
Ddc
|
dopa decarboxylase |
chr7_-_34654342 | 1.42 |
ENSMUST00000108069.1
|
Kctd15
|
potassium channel tetramerisation domain containing 15 |
chr9_+_119102463 | 1.41 |
ENSMUST00000140326.1
ENSMUST00000165231.1 |
Dlec1
|
deleted in lung and esophageal cancer 1 |
chr10_-_83337845 | 1.40 |
ENSMUST00000039956.5
|
Slc41a2
|
solute carrier family 41, member 2 |
chr2_+_67748212 | 1.40 |
ENSMUST00000180887.1
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr19_-_29047847 | 1.40 |
ENSMUST00000025696.4
|
Ak3
|
adenylate kinase 3 |
chr3_+_81999461 | 1.39 |
ENSMUST00000107736.1
|
Asic5
|
acid-sensing (proton-gated) ion channel family member 5 |
chr1_+_88200601 | 1.37 |
ENSMUST00000049289.8
|
Ugt1a2
|
UDP glucuronosyltransferase 1 family, polypeptide A2 |
chr7_-_99695572 | 1.36 |
ENSMUST00000137914.1
|
Slco2b1
|
solute carrier organic anion transporter family, member 2b1 |
chr10_+_40629987 | 1.36 |
ENSMUST00000019977.7
|
Ddo
|
D-aspartate oxidase |
chr6_-_83677807 | 1.35 |
ENSMUST00000037882.6
|
Cd207
|
CD207 antigen |
chr14_-_37048957 | 1.34 |
ENSMUST00000022338.5
|
Rgr
|
retinal G protein coupled receptor |
chr5_-_120812484 | 1.34 |
ENSMUST00000125547.1
|
Oas1c
|
2'-5' oligoadenylate synthetase 1C |
chr17_-_34000257 | 1.33 |
ENSMUST00000087189.6
ENSMUST00000173075.1 ENSMUST00000172760.1 ENSMUST00000172912.1 ENSMUST00000025181.10 |
H2-K1
|
histocompatibility 2, K1, K region |
chr11_-_70514608 | 1.33 |
ENSMUST00000021179.3
|
Vmo1
|
vitelline membrane outer layer 1 homolog (chicken) |
chr13_-_56296551 | 1.32 |
ENSMUST00000021970.9
|
Cxcl14
|
chemokine (C-X-C motif) ligand 14 |
chr8_-_71537402 | 1.32 |
ENSMUST00000051672.7
|
Bst2
|
bone marrow stromal cell antigen 2 |
chr4_-_96664112 | 1.31 |
ENSMUST00000030299.7
|
Cyp2j5
|
cytochrome P450, family 2, subfamily j, polypeptide 5 |
chr18_-_31820413 | 1.31 |
ENSMUST00000165131.2
|
Gm6665
|
predicted gene 6665 |
chr2_-_52335134 | 1.31 |
ENSMUST00000075301.3
|
Neb
|
nebulin |
chr14_-_51913393 | 1.30 |
ENSMUST00000004673.7
ENSMUST00000111632.3 |
Ndrg2
|
N-myc downstream regulated gene 2 |
chr8_-_93337195 | 1.28 |
ENSMUST00000044602.7
|
Ces1g
|
carboxylesterase 1G |
chrX_+_59999436 | 1.28 |
ENSMUST00000033477.4
|
F9
|
coagulation factor IX |
chr15_-_76307101 | 1.27 |
ENSMUST00000171340.1
|
Oplah
|
5-oxoprolinase (ATP-hydrolysing) |
chr14_+_29018205 | 1.27 |
ENSMUST00000055662.2
|
Lrtm1
|
leucine-rich repeats and transmembrane domains 1 |
chr7_+_44207307 | 1.27 |
ENSMUST00000077354.4
|
Klk1b4
|
kallikrein 1-related pepidase b4 |
chr3_+_19957088 | 1.27 |
ENSMUST00000108328.1
|
Cp
|
ceruloplasmin |
chr10_+_127801145 | 1.26 |
ENSMUST00000071646.1
|
Rdh16
|
retinol dehydrogenase 16 |
chr7_-_19692596 | 1.26 |
ENSMUST00000108451.2
ENSMUST00000045035.4 |
Apoc1
|
apolipoprotein C-I |
chr17_-_57247632 | 1.24 |
ENSMUST00000005975.6
|
Gpr108
|
G protein-coupled receptor 108 |
chr18_-_3281036 | 1.24 |
ENSMUST00000049942.6
ENSMUST00000139537.1 ENSMUST00000124747.1 |
Crem
|
cAMP responsive element modulator |
chr3_-_89764581 | 1.23 |
ENSMUST00000029562.3
|
Chrnb2
|
cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) |
chr1_+_88211956 | 1.22 |
ENSMUST00000073049.6
|
Ugt1a1
|
UDP glucuronosyltransferase 1 family, polypeptide A1 |
chr11_-_116198701 | 1.21 |
ENSMUST00000072948.4
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr7_-_114562945 | 1.21 |
ENSMUST00000119712.1
ENSMUST00000032908.8 |
Cyp2r1
|
cytochrome P450, family 2, subfamily r, polypeptide 1 |
chr5_-_86518578 | 1.21 |
ENSMUST00000134179.1
|
Tmprss11g
|
transmembrane protease, serine 11g |
chr19_-_7802578 | 1.20 |
ENSMUST00000120522.1
ENSMUST00000065634.7 |
Slc22a26
|
solute carrier family 22 (organic cation transporter), member 26 |
chr4_-_108118528 | 1.20 |
ENSMUST00000030340.8
|
Scp2
|
sterol carrier protein 2, liver |
chr3_+_89229046 | 1.18 |
ENSMUST00000041142.3
|
Muc1
|
mucin 1, transmembrane |
chr10_-_28986280 | 1.16 |
ENSMUST00000152363.1
ENSMUST00000015663.6 |
2310057J18Rik
|
RIKEN cDNA 2310057J18 gene |
chr14_+_65970804 | 1.14 |
ENSMUST00000138191.1
|
Clu
|
clusterin |
chr1_-_131276914 | 1.14 |
ENSMUST00000161764.1
|
Ikbke
|
inhibitor of kappaB kinase epsilon |
chr1_+_135818593 | 1.14 |
ENSMUST00000038760.8
|
Lad1
|
ladinin |
chr5_-_87092546 | 1.13 |
ENSMUST00000132667.1
ENSMUST00000145617.1 ENSMUST00000094649.4 |
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr19_+_39992424 | 1.13 |
ENSMUST00000049178.2
|
Cyp2c37
|
cytochrome P450, family 2. subfamily c, polypeptide 37 |
chr8_+_45069374 | 1.12 |
ENSMUST00000130141.1
|
Mtnr1a
|
melatonin receptor 1A |
chr7_-_126625676 | 1.12 |
ENSMUST00000032961.3
|
Nupr1
|
nuclear protein transcription regulator 1 |
chr6_+_128662379 | 1.11 |
ENSMUST00000032518.4
|
Clec2h
|
C-type lectin domain family 2, member h |
chr4_-_115496129 | 1.10 |
ENSMUST00000030487.2
|
Cyp4a14
|
cytochrome P450, family 4, subfamily a, polypeptide 14 |
chr8_+_107150621 | 1.10 |
ENSMUST00000034400.3
|
Cyb5b
|
cytochrome b5 type B |
chr18_-_84649924 | 1.10 |
ENSMUST00000070139.7
|
Cndp1
|
carnosine dipeptidase 1 (metallopeptidase M20 family) |
chr7_+_43950614 | 1.10 |
ENSMUST00000072204.4
|
Klk1b8
|
kallikrein 1-related peptidase b8 |
chr10_-_89533550 | 1.09 |
ENSMUST00000105297.1
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4 |
chr13_-_41847626 | 1.08 |
ENSMUST00000121404.1
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr1_-_139608282 | 1.08 |
ENSMUST00000170441.2
|
Cfhr3
|
complement factor H-related 3 |
chr6_-_85820936 | 1.06 |
ENSMUST00000174143.1
|
Gm11128
|
predicted gene 11128 |
chr4_+_20008357 | 1.05 |
ENSMUST00000117632.1
ENSMUST00000098244.1 |
Ttpa
|
tocopherol (alpha) transfer protein |
chrX_-_75874536 | 1.05 |
ENSMUST00000033547.7
|
Pls3
|
plastin 3 (T-isoform) |
chr18_+_57533780 | 1.04 |
ENSMUST00000079738.3
ENSMUST00000135806.1 ENSMUST00000127130.2 |
1700011I03Rik
|
RIKEN cDNA 1700011I03 gene |
chr10_-_18234930 | 1.04 |
ENSMUST00000052648.8
ENSMUST00000080860.6 ENSMUST00000173243.1 |
Ccdc28a
|
coiled-coil domain containing 28A |
chr14_+_51091077 | 1.04 |
ENSMUST00000022428.5
ENSMUST00000171688.1 |
Rnase4
Ang
|
ribonuclease, RNase A family 4 angiogenin, ribonuclease, RNase A family, 5 |
chr9_-_106476104 | 1.04 |
ENSMUST00000156426.1
|
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr19_+_12695783 | 1.03 |
ENSMUST00000025598.3
ENSMUST00000138545.1 ENSMUST00000154822.1 |
Keg1
|
kidney expressed gene 1 |
chr1_+_13668739 | 1.03 |
ENSMUST00000088542.3
|
Xkr9
|
X Kell blood group precursor related family member 9 homolog |
chr9_+_107296682 | 1.03 |
ENSMUST00000168260.1
|
Cish
|
cytokine inducible SH2-containing protein |
chr16_-_21787796 | 1.03 |
ENSMUST00000023559.5
|
Ehhadh
|
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase |
chr10_-_41709297 | 1.02 |
ENSMUST00000019955.9
ENSMUST00000099932.3 |
Ccdc162
|
coiled-coil domain containing 162 |
chr1_+_58113136 | 1.02 |
ENSMUST00000040999.7
|
Aox3
|
aldehyde oxidase 3 |
chr1_-_155812859 | 1.01 |
ENSMUST00000035325.8
|
Qsox1
|
quiescin Q6 sulfhydryl oxidase 1 |
chr9_-_21989427 | 1.01 |
ENSMUST00000045726.6
|
Rgl3
|
ral guanine nucleotide dissociation stimulator-like 3 |
chr7_-_29248375 | 1.00 |
ENSMUST00000032808.4
|
2200002D01Rik
|
RIKEN cDNA 2200002D01 gene |
chr16_+_62854299 | 1.00 |
ENSMUST00000023629.8
|
Pros1
|
protein S (alpha) |
chr1_+_130800902 | 1.00 |
ENSMUST00000112477.2
ENSMUST00000027670.3 |
Fcamr
|
Fc receptor, IgA, IgM, high affinity |
chr4_+_47288057 | 0.98 |
ENSMUST00000140413.1
ENSMUST00000107731.2 |
Col15a1
|
collagen, type XV, alpha 1 |
chr16_+_43510267 | 0.97 |
ENSMUST00000114695.2
|
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr8_-_110805863 | 0.97 |
ENSMUST00000150680.1
ENSMUST00000076846.4 |
Il34
|
interleukin 34 |
chr10_+_87859593 | 0.96 |
ENSMUST00000126490.1
|
Igf1
|
insulin-like growth factor 1 |
chr6_+_24733241 | 0.96 |
ENSMUST00000031690.5
|
Hyal6
|
hyaluronoglucosaminidase 6 |
chr1_-_155812805 | 0.96 |
ENSMUST00000111764.2
|
Qsox1
|
quiescin Q6 sulfhydryl oxidase 1 |
chr13_-_41847599 | 0.95 |
ENSMUST00000179758.1
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr4_-_142015056 | 0.95 |
ENSMUST00000105780.1
|
Fhad1
|
forkhead-associated (FHA) phosphopeptide binding domain 1 |
chr8_-_36953139 | 0.94 |
ENSMUST00000179501.1
|
Dlc1
|
deleted in liver cancer 1 |
chr12_+_57564111 | 0.94 |
ENSMUST00000101398.3
|
Ttc6
|
tetratricopeptide repeat domain 6 |
chr11_-_115062177 | 0.93 |
ENSMUST00000062787.7
|
Cd300e
|
CD300e antigen |
chr17_-_57222827 | 0.93 |
ENSMUST00000177425.1
|
C3
|
complement component 3 |
chr8_+_13895816 | 0.93 |
ENSMUST00000084055.7
|
Gm7676
|
predicted gene 7676 |
chr10_-_128409632 | 0.92 |
ENSMUST00000172348.1
ENSMUST00000166608.1 ENSMUST00000164199.1 ENSMUST00000171370.1 ENSMUST00000026439.7 |
Nabp2
|
nucleic acid binding protein 2 |
chr7_-_44669308 | 0.92 |
ENSMUST00000148487.1
|
Myh14
|
myosin, heavy polypeptide 14 |
chr10_-_42583628 | 0.92 |
ENSMUST00000019938.4
|
Nr2e1
|
nuclear receptor subfamily 2, group E, member 1 |
chr3_-_89322883 | 0.91 |
ENSMUST00000029673.5
|
Efna3
|
ephrin A3 |
chr11_-_50887443 | 0.91 |
ENSMUST00000050595.6
ENSMUST00000163301.1 ENSMUST00000109131.1 ENSMUST00000125749.1 |
Zfp454
|
zinc finger protein 454 |
chr3_-_98753465 | 0.91 |
ENSMUST00000094050.4
ENSMUST00000090743.6 |
Hsd3b3
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 |
chr3_+_94362444 | 0.91 |
ENSMUST00000169433.1
|
C2cd4d
|
C2 calcium-dependent domain containing 4D |
chr7_-_46715676 | 0.90 |
ENSMUST00000006956.7
|
Saa3
|
serum amyloid A 3 |
chr15_-_75566608 | 0.90 |
ENSMUST00000163116.1
ENSMUST00000023241.5 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr13_-_41828418 | 0.90 |
ENSMUST00000137905.1
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr9_+_65265173 | 0.90 |
ENSMUST00000048762.1
|
Cilp
|
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase |
chr17_-_36058371 | 0.90 |
ENSMUST00000113742.2
|
Gm11127
|
predicted gene 11127 |
chr16_-_90934506 | 0.89 |
ENSMUST00000142340.1
|
1110004E09Rik
|
RIKEN cDNA 1110004E09 gene |
chr19_+_39510844 | 0.89 |
ENSMUST00000025968.4
|
Cyp2c39
|
cytochrome P450, family 2, subfamily c, polypeptide 39 |
chr4_-_114908892 | 0.89 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chr15_+_99392948 | 0.89 |
ENSMUST00000161250.1
ENSMUST00000160635.1 ENSMUST00000161778.1 |
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr2_-_168712853 | 0.89 |
ENSMUST00000123156.1
ENSMUST00000156555.1 |
Atp9a
|
ATPase, class II, type 9A |
chr9_+_54538984 | 0.88 |
ENSMUST00000060242.5
ENSMUST00000118413.1 |
Sh2d7
|
SH2 domain containing 7 |
chr3_+_19957240 | 0.88 |
ENSMUST00000108325.2
|
Cp
|
ceruloplasmin |
chr7_+_28180226 | 0.88 |
ENSMUST00000172467.1
|
Dyrk1b
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
chr15_+_52295509 | 0.88 |
ENSMUST00000037240.2
|
Slc30a8
|
solute carrier family 30 (zinc transporter), member 8 |
chr11_-_53773187 | 0.87 |
ENSMUST00000170390.1
|
Gm17334
|
predicted gene, 17334 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 6.4 | GO:0034757 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
1.5 | 4.5 | GO:0009095 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
1.5 | 5.8 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
1.1 | 3.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
1.0 | 2.1 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.0 | 3.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.0 | 10.9 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.7 | 7.3 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.7 | 1.3 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) |
0.6 | 1.9 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.6 | 2.5 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.6 | 1.8 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.5 | 2.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.5 | 2.5 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.5 | 1.9 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.5 | 7.6 | GO:0031000 | response to caffeine(GO:0031000) |
0.5 | 3.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.5 | 1.8 | GO:0010986 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
0.5 | 1.4 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.4 | 3.4 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.4 | 5.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.4 | 1.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.4 | 5.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.4 | 1.2 | GO:0015866 | ADP transport(GO:0015866) |
0.4 | 1.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.4 | 0.7 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.4 | 1.1 | GO:0019740 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) histone H3-R17 methylation(GO:0034971) |
0.4 | 3.3 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.4 | 0.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.4 | 1.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.4 | 1.4 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 1.7 | GO:0031437 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.3 | 1.0 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.3 | 1.0 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.3 | 1.0 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.3 | 1.0 | GO:1902022 | L-lysine transport(GO:1902022) |
0.3 | 2.0 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.3 | 1.9 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 0.6 | GO:2000554 | regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
0.3 | 1.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 1.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 1.2 | GO:0032379 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.3 | 1.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 1.2 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
0.3 | 1.7 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.3 | 1.7 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 0.9 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.3 | 1.7 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.3 | 0.8 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.3 | 1.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 3.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 6.9 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.2 | 0.2 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.2 | 0.7 | GO:0048627 | myoblast development(GO:0048627) |
0.2 | 0.9 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.2 | 0.4 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.2 | 0.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.6 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.2 | 1.3 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.2 | 0.6 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 1.0 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.2 | 1.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 0.4 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.2 | 3.8 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 0.8 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 0.6 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.2 | 0.6 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.2 | 2.6 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 1.1 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.2 | 0.9 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.2 | 0.9 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 0.7 | GO:0015851 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.2 | 0.7 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.2 | 0.9 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.2 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.2 | 0.5 | GO:0006589 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
0.2 | 0.5 | GO:0043387 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) |
0.2 | 0.7 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.2 | 1.2 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 23.6 | GO:0007586 | digestion(GO:0007586) |
0.2 | 0.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 1.4 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.2 | 0.5 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.2 | 1.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.4 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.1 | 0.4 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.1 | 0.6 | GO:0021666 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.1 | 0.6 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 0.3 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.4 | GO:1990168 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 2.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.5 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 3.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.5 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.5 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.1 | 1.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.4 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.7 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 1.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.5 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.6 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 2.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 2.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.5 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.1 | 0.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 2.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.7 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 1.4 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.6 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.3 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.1 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.4 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.1 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.4 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.1 | 0.4 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 0.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 1.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.3 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.4 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 0.7 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.8 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 1.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.4 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.1 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.3 | GO:2000077 | transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) positive regulation of establishment of Sertoli cell barrier(GO:1904446) negative regulation of type B pancreatic cell development(GO:2000077) |
0.1 | 0.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 0.4 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.1 | 0.4 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.1 | 0.3 | GO:0042697 | menopause(GO:0042697) |
0.1 | 0.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 2.9 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 1.0 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.3 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.6 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.3 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.1 | 2.1 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 | 0.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.5 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 3.3 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.2 | GO:0003285 | septum secundum development(GO:0003285) |
0.1 | 0.4 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.3 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 0.4 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 1.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 1.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.2 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.1 | 0.3 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.1 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.4 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 1.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 2.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.5 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.1 | 0.2 | GO:0006222 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 1.0 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.4 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 0.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.4 | GO:0035546 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.1 | 0.3 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.1 | 0.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.4 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 1.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 6.0 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 2.6 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 2.6 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:0002874 | chronic inflammatory response to antigenic stimulus(GO:0002439) regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.3 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.1 | 1.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.2 | GO:1902739 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 1.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.3 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 0.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.5 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.1 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.5 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.5 | GO:1900042 | interleukin-4 secretion(GO:0072602) positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.1 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
0.1 | 0.2 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.3 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.3 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.1 | 0.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.2 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.1 | 0.6 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.1 | 0.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.2 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.3 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 1.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 3.6 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.1 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.8 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.4 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 0.4 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 3.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.0 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.0 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.0 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.0 | 0.2 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 0.0 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.0 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.0 | 0.5 | GO:0019934 | cGMP-mediated signaling(GO:0019934) cellular response to nitric oxide(GO:0071732) |
0.0 | 0.3 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.0 | 0.8 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.2 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.0 | 0.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.6 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.3 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.8 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.0 | 0.2 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.0 | 0.6 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.1 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 0.2 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.0 | 0.2 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.0 | 0.0 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.0 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.2 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.1 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 1.8 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.2 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.1 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.0 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.4 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.1 | GO:0090346 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.0 | 0.8 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.7 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.0 | 1.9 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 2.4 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.0 | 0.1 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.0 | 0.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.0 | 0.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.9 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.7 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.5 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.0 | 0.4 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 0.9 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.2 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:0061386 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.0 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.2 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 1.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 1.7 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.5 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.3 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.2 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.0 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.5 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.5 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.0 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.3 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.3 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.0 | 0.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.3 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 1.1 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.2 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.2 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 2.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.2 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.0 | 0.7 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.0 | 0.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 1.9 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.7 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.0 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.2 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.2 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.1 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.0 | 0.5 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.0 | 0.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.2 | GO:0021678 | third ventricle development(GO:0021678) |
0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.5 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.0 | 0.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.0 | 0.4 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.0 | 0.3 | GO:0097576 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.1 | GO:0097531 | mast cell chemotaxis(GO:0002551) mast cell migration(GO:0097531) |
0.0 | 0.2 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.3 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.6 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
0.0 | 0.7 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.0 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
0.0 | 0.0 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.6 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.3 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.0 | 0.4 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) positive regulation of lipoprotein lipase activity(GO:0051006) positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.3 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.7 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.0 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.0 | 0.1 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.0 | GO:0033505 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
0.0 | 0.1 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.0 | 0.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.5 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.3 | GO:0032355 | response to estradiol(GO:0032355) |
0.0 | 0.3 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.2 | GO:0033561 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0005713 | recombination nodule(GO:0005713) |
0.4 | 1.3 | GO:0044317 | rod spherule(GO:0044317) |
0.4 | 1.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.4 | 11.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 4.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 1.6 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 2.0 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 0.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 2.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.8 | GO:0097447 | dendritic tree(GO:0097447) |
0.2 | 2.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 1.7 | GO:0042567 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 1.1 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.2 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 0.6 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.2 | 0.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 2.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.2 | 1.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.6 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.1 | 0.4 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.1 | 0.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 1.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 1.0 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.1 | 0.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 3.0 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 1.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 1.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.8 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 1.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.2 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.1 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.2 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.1 | 0.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 4.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.7 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.9 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 0.5 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.4 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.6 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 1.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.1 | 0.3 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.1 | 0.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 1.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 4.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.4 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 0.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.3 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 0.3 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.1 | 0.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 4.5 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 98.4 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 5.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.8 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 2.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.5 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 0.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 1.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.5 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.6 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.6 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 1.0 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 4.9 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.1 | GO:1990423 | Dsl1p complex(GO:0070939) RZZ complex(GO:1990423) |
0.0 | 0.8 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 6.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 2.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 1.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 1.3 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 1.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 1.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.9 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 1.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.7 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 6.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.1 | GO:0090537 | CERF complex(GO:0090537) |
0.0 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 2.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 18.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.1 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) RNA polymerase II transcription repressor complex(GO:0090571) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 10.1 | GO:0005009 | insulin-activated receptor activity(GO:0005009) pheromone activity(GO:0005186) |
1.3 | 8.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.9 | 4.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.8 | 3.3 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.7 | 2.9 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.7 | 3.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.7 | 4.2 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.6 | 1.9 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.6 | 3.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 2.0 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.5 | 18.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.5 | 1.4 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.5 | 1.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.4 | 2.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 1.2 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.4 | 1.9 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.4 | 7.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.4 | 3.6 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 1.1 | GO:0008431 | vitamin E binding(GO:0008431) |
0.3 | 1.4 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.3 | 1.0 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.3 | 1.4 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.3 | 2.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.3 | 1.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 1.0 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.3 | 0.9 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.3 | 1.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 1.2 | GO:0033814 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.3 | 61.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 1.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.3 | 0.9 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.3 | 0.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 3.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 0.8 | GO:0030338 | CMP-N-acetylneuraminate monooxygenase activity(GO:0030338) |
0.3 | 1.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 1.5 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 0.7 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.2 | 3.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.2 | 0.7 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.2 | 1.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 1.0 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.2 | 1.0 | GO:0016623 | aldehyde oxidase activity(GO:0004031) xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 0.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 0.6 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.2 | 0.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 0.8 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.2 | 2.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 0.5 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.2 | 1.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 0.5 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.2 | 1.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 1.9 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.8 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 0.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.2 | 0.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.5 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.2 | 1.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 0.5 | GO:0016520 | gonadotropin-releasing hormone receptor activity(GO:0004968) growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.8 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
0.2 | 0.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 0.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 4.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.7 | GO:0015189 | L-ornithine transmembrane transporter activity(GO:0000064) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 2.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.8 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 1.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 3.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 1.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.4 | GO:0035276 | ethanol binding(GO:0035276) |
0.1 | 1.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 1.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.6 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 0.4 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
0.1 | 0.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 1.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 2.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.3 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.1 | 0.6 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 1.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 4.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.3 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) serine binding(GO:0070905) |
0.1 | 0.5 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 2.2 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.4 | GO:0004905 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
0.1 | 0.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.4 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 0.9 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 2.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 1.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.3 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.1 | 0.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.4 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 1.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 10.7 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 1.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.3 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.1 | 8.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.1 | 2.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.4 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 1.0 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.6 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 2.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.5 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.1 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.3 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.1 | 1.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.5 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.3 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.3 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 0.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.5 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.2 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.2 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.1 | 0.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.9 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.8 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.1 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.6 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 0.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.2 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.1 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.2 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 0.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 4.4 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 0.2 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.1 | 0.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.8 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 1.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.6 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 1.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 1.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.0 | 0.8 | GO:0043855 | cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 1.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.9 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.0 | 0.2 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.0 | 1.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 9.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.2 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.4 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 2.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 2.1 | GO:0008238 | exopeptidase activity(GO:0008238) |
0.0 | 0.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 0.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.6 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 1.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.0 | 0.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.0 | 0.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.0 | 0.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.0 | 0.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 1.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.3 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.3 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.4 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.0 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.1 | GO:0070698 | nodal binding(GO:0038100) type I activin receptor binding(GO:0070698) |
0.0 | 0.4 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 1.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.2 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 1.0 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.2 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.0 | 0.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 1.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.0 | GO:0005302 | L-tyrosine transmembrane transporter activity(GO:0005302) |
0.0 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 1.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.0 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.0 | 1.6 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 3.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 16.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 1.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 2.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 1.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 1.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 2.3 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 6.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 2.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 7.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.4 | 4.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 4.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 1.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 3.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 16.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 1.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 2.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 2.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 4.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 2.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 0.4 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.2 | 1.4 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 5.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 2.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 2.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 1.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 3.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 4.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 1.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 3.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 6.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 2.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.9 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 1.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 1.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 1.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 1.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 2.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |